{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:33:11Z","timestamp":1742380391239,"version":"3.30.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.humimm.2024.111154","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:31:53Z","timestamp":1729074713000},"page":"111154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated Interleukin-21 expression is correlated with systemic sclerosis\u2019 severity in Tunisian patients"],"prefix":"10.1016","volume":"85","author":[{"given":"Akram","family":"Dlala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Gabsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Ben Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alya","family":"Boutabba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Nacer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadoua","family":"Missaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilel","family":"Neili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Sa\u00efd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Smiti-Khanfir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Triki-Marrakchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2024.111154_b0005","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic sclerosis: environmental factors","volume":"36","author":"Mora","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2024.111154_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.humimm.2024.111154_b0015","article-title":"Cerebral infarction caused by systemic sclerosis: a case report","volume":"49","author":"Wang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.humimm.2024.111154_b0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13023-021-01844-y","article-title":"French recommendations for the management of systemic sclerosis","volume":"16","author":"Hachulla","year":"2021","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.humimm.2024.111154_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2014.11.005","article-title":"Increased IL-21\/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease","volume":"72","author":"Guan","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.humimm.2024.111154_b0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2024.111154_b0035","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3899\/jrheum.101377","article-title":"Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-\u03b1","volume":"38","author":"Ren","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2024.111154_b0040","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.humimm.2024.111154_b0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ibd.20475","article-title":"IL-23\/IL-17 immunity as a hallmark of Crohn\u2019s disease","volume":"14","author":"H\u00f6ltt\u00e4","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.humimm.2024.111154_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2397198318765061","article-title":"The challenges and controversies of measuring disease activity in systemic sclerosis","volume":"3","author":"Ross","year":"2018","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.humimm.2024.111154_b0055","first-page":"177","article-title":"Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes","volume":"1","author":"Peoples","year":"2016","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.humimm.2024.111154_b0060","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/j.lpm.2019.07.037","article-title":"Clinical and serological profile of systemic sclerosis in Tunisia: a retrospective observational study","volume":"48","author":"Ben Salah","year":"2019","journal-title":"Presse Med."},{"key":"10.1016\/j.humimm.2024.111154_b0065","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1007\/s10238-023-01125-x","article-title":"Type 2 cytokines and scleroderma interstitial lung disease","volume":"23","author":"Pellicano","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2024.111154_b0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1756-185X.12522","article-title":"Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis","volume":"19","author":"Lei","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.humimm.2024.111154_b0075","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cbin.10410","article-title":"IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice","volume":"39","author":"Lei","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.humimm.2024.111154_b0080","first-page":"5251","article-title":"IL-21 promotes pulmonary fibrosis through the induction of pro-fibrotic CD8+ T cells","volume":"195","author":"Brodeur","year":"2015","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"10.1016\/j.humimm.2024.111154_b0085","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1002\/ctm2.509","article-title":"Protective function of interleukin-22 in pulmonary fibrosis","volume":"11","author":"Gu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.humimm.2024.111154_b0090","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.20092054","article-title":"Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A","volume":"207","author":"Sonnenberg","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2024.111154_b0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13075-022-02977-6","article-title":"IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice","volume":"24","author":"Qu","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2024.111154_b0100","doi-asserted-by":"crossref","first-page":"36436","DOI":"10.1038\/srep36436","article-title":"Interleukin-22 ameliorates liver fibrosis through miR-200a\/beta-catenin","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2024.111154_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12985-014-0230-z","article-title":"IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis","volume":"11","author":"Guo","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.humimm.2024.111154_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/209179","article-title":"Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis","volume":"2013","author":"Liang","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2024.111154_b0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/08923973.2020.1799388","article-title":"The double-edged role of IL-22 in organ fibrosis","volume":"42","author":"Chen","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.humimm.2024.111154_b0120","doi-asserted-by":"crossref","first-page":"E2677","DOI":"10.1073\/pnas.1424774112","article-title":"Interleukin-6\/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension","volume":"112","author":"Hashimoto-Kataoka","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2024.111154_b0125","series-title":"Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension","first-page":"157","article-title":"Inflammatory cytokines in the pathogenesis of pulmonary arterial hypertension","author":"Nakaoka","year":"2020"},{"key":"10.1016\/j.humimm.2024.111154_b0130","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20100061","article-title":"\u03b3\u03b4 T cells protect against lung fibrosis via IL-22","volume":"207","author":"Simonian","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2024.111154_b0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imr.12027","article-title":"IL -22, not simply a Th17 cytokine","volume":"252","author":"Rutz","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2024.111154_b0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","article-title":"Th17 cytokines in mucosal immunity and inflammation","volume":"5","author":"Guglani","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.humimm.2024.111154_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biopha.2018.09.037","article-title":"Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis","volume":"108","author":"Mo","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2024.111154_b0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41435-019-0067-y","article-title":"The IL-23\/IL-17 pathway in human chronic inflammatory diseases\u2014new insight from genetics and targeted therapies","volume":"20","author":"Bianchi","year":"2019","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2024.111154_b0155","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/ijms20143394","article-title":"Th17 cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases","volume":"20","author":"Bunte","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2024.111154_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2262","article-title":"TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity","volume":"5","author":"Harbour","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.humimm.2024.111154_b0165","doi-asserted-by":"crossref","first-page":"2250075","DOI":"10.1002\/eji.202250075","article-title":"Interleukin-21 in autoimmune and inflammatory skin diseases","volume":"53","author":"Mesas-Fern\u00e1ndez","year":"2023","journal-title":"Eur. J. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:34:02Z","timestamp":1733880842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0198885924004178"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111154","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Interleukin-21 expression is correlated with systemic sclerosis\u2019 severity in Tunisian patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111154"}}